Reply to Brown and Burleigh, Molecular and cellular mechanisms leading to topical steroid withdrawal syndrome remain unexplained and warrant further research

Affiliations

• ¹ Laboratory of Clinical Immunology and Microbiology (LCIM), Epithelial Therapeutics Unit, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD.
• ² LCIM, NIAID, NIH, Bethesda, MD.
• ³ Functional Immunogenomics Section, Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, MD.
• ⁴ Biological Imaging Section, Research Technology Branch, NIAID, NIH, Bethesda, MD.
• ⁵ Genomic Research Section, Research Technologies Branch (RTB), Rocky Mountain Laboratories, NIAID, NIH, Hamilton, MT.
• ⁶ Integrated Data Science Section, RTB, NIAID, NIH, Bethesda, MD.
• ⁷ Lymphocyte Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD.
• ⁸ Centralized Sequencing Program, Division of Intramural Research, NIAID, Bethesda, MD.
• ⁹ Allergy & Asthma Network, Fairfax, Virginia.
• ¹⁰ International Topical Steroid Awareness Network, Dacula, Georgia.
• ¹¹ Laboratory of Clinical Immunology and Microbiology (LCIM), Epithelial Therapeutics Unit, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD. Electronic address: mylesi@niaid.nih.gov.